Screening and Interpreting Hepatitis B Serologic Results to Inform Treatment Decisions
This activity offers CE credit for:%>
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, September 27, 2022
Note: Credit Is No Longer Available
|Kimberly A. Forde, MD, PhD, MHS (Moderator)
Associate Professor of Medicine
Section of Hepatology, Department of Medicine
Temple University Hospital, Lewis Katz School of Medicine
|Lauren M. Hynicka, PharmD, BCPS
Associate Professor of Pharmacotherapy
University of Maryland School of Pharmacy
The burden of disease associated with hepatitis B virus (HBV) infection is significant. The statistics are staggering, as a broad cohort of individuals remain undiagnosed, not immunized, and untreated. Addressing the gaps in screening, treating, and monitoring requires active engagement from all members of the health care team—primary care providers, specialists, advanced practice professionals, nurses, and pharmacists. In their role as teachers, advisors, watchdogs, and “nudges,” pharmacists must be prepared for questions from patients and communication with providers.
This CMEO webcast features expert faculty discussing the ways pharmacists can best engage with at-risk patients to promote screening for HBV.
At the end of this CE activity, participants should be able to:
- Initiate discussions with at-risk patients to promote screening for HBV in the primary care setting.
Supported by an educational grant from Gilead Sciences, Inc.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .75 contact hours (0.075 CEUs) Universal Activity Number: Enduring: JA0007185-0000-21-145-H01-P
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Forde has no disclosures to report.
Dr. Hynicka has no disclosures to report.
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).